Hypertension, antihypertensive medication use, and risk of psoriasis

Shaowei Wu, Jiali Han, Wen Qing Li, Abrar A. Qureshi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

IMPORTANCE Individuals with psoriasis have an elevated risk of hypertension, and antihypertensive medications, especially β-blockers, have been linked to psoriasis development. However, the association of prior existing hypertension and antihypertensive medications with risk of incident psoriasis has not been assessed using prospective data.

OBJECTIVE To evaluate the association of hypertension and antihypertensive medications with risk of psoriasis.

DESIGN, SETTING, AND PARTICIPANTS We performed a prospective cohort study (June 1, 1996, to June 1, 2008) of 77 728 US women from the Nurses' Health Study who provided biennially updated data on hypertension and antihypertensive medications.

MAIN OUTCOMES AND MEASURES Physician-diagnosed psoriasis.

RESULTS A total of 843 incident psoriasis cases were documented during 1 066 339 person-years of follow-up. Compared with normotensive women, women with a hypertension duration of 6 years or more were at a higher risk of developing psoriasis (hazard ratio [HR], 1.27; 95%CI, 1.03-1.57). In stratified analysis, the risk of psoriasis was higher among hypertensive women without medication use (HR, 1.49; 95%CI, 1.15-1.92) and among hypertensive women with current medication use (HR, 1.31; 95%CI, 1.10-1.55) when compared with normotensive participants without medication use. Compared with women who never used β-blockers, the multivariate HRs for psoriasis for women who regularly used β-blockers were 1.11 (95%CI, 0.82-1.51) for 1 to 2 years of use, 1.06 (95%CI, 0.79-1.40) for 3 to 5 years of use, and 1.39 (95%CI, 1.11-1.73) for 6 years or more of use (P for trend = .009). No association was found between use of other individual antihypertensive drugs and risk of psoriasis.

CONCLUSIONS AND RELEVANCE Long-term hypertensive status is associated with an increased risk of psoriasis. Long-term regular use of β-blockers may also increase the risk of psoriasis.

Original languageEnglish (US)
Pages (from-to)957-963
Number of pages7
JournalJAMA Dermatology
Volume150
Issue number9
DOIs
StatePublished - Jan 1 2014

Fingerprint

Psoriasis
Antihypertensive Agents
Hypertension
Women's Health
Cohort Studies
Nurses
Prospective Studies
Physicians

ASJC Scopus subject areas

  • Dermatology

Cite this

Hypertension, antihypertensive medication use, and risk of psoriasis. / Wu, Shaowei; Han, Jiali; Li, Wen Qing; Qureshi, Abrar A.

In: JAMA Dermatology, Vol. 150, No. 9, 01.01.2014, p. 957-963.

Research output: Contribution to journalArticle

Wu, Shaowei ; Han, Jiali ; Li, Wen Qing ; Qureshi, Abrar A. / Hypertension, antihypertensive medication use, and risk of psoriasis. In: JAMA Dermatology. 2014 ; Vol. 150, No. 9. pp. 957-963.
@article{ac863692d6344d9a856b683437db2fbe,
title = "Hypertension, antihypertensive medication use, and risk of psoriasis",
abstract = "IMPORTANCE Individuals with psoriasis have an elevated risk of hypertension, and antihypertensive medications, especially β-blockers, have been linked to psoriasis development. However, the association of prior existing hypertension and antihypertensive medications with risk of incident psoriasis has not been assessed using prospective data.OBJECTIVE To evaluate the association of hypertension and antihypertensive medications with risk of psoriasis.DESIGN, SETTING, AND PARTICIPANTS We performed a prospective cohort study (June 1, 1996, to June 1, 2008) of 77 728 US women from the Nurses' Health Study who provided biennially updated data on hypertension and antihypertensive medications.MAIN OUTCOMES AND MEASURES Physician-diagnosed psoriasis.RESULTS A total of 843 incident psoriasis cases were documented during 1 066 339 person-years of follow-up. Compared with normotensive women, women with a hypertension duration of 6 years or more were at a higher risk of developing psoriasis (hazard ratio [HR], 1.27; 95{\%}CI, 1.03-1.57). In stratified analysis, the risk of psoriasis was higher among hypertensive women without medication use (HR, 1.49; 95{\%}CI, 1.15-1.92) and among hypertensive women with current medication use (HR, 1.31; 95{\%}CI, 1.10-1.55) when compared with normotensive participants without medication use. Compared with women who never used β-blockers, the multivariate HRs for psoriasis for women who regularly used β-blockers were 1.11 (95{\%}CI, 0.82-1.51) for 1 to 2 years of use, 1.06 (95{\%}CI, 0.79-1.40) for 3 to 5 years of use, and 1.39 (95{\%}CI, 1.11-1.73) for 6 years or more of use (P for trend = .009). No association was found between use of other individual antihypertensive drugs and risk of psoriasis.CONCLUSIONS AND RELEVANCE Long-term hypertensive status is associated with an increased risk of psoriasis. Long-term regular use of β-blockers may also increase the risk of psoriasis.",
author = "Shaowei Wu and Jiali Han and Li, {Wen Qing} and Qureshi, {Abrar A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1001/jamadermatol.2013.9957",
language = "English (US)",
volume = "150",
pages = "957--963",
journal = "JAMA Dermatology",
issn = "2168-6068",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Hypertension, antihypertensive medication use, and risk of psoriasis

AU - Wu, Shaowei

AU - Han, Jiali

AU - Li, Wen Qing

AU - Qureshi, Abrar A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - IMPORTANCE Individuals with psoriasis have an elevated risk of hypertension, and antihypertensive medications, especially β-blockers, have been linked to psoriasis development. However, the association of prior existing hypertension and antihypertensive medications with risk of incident psoriasis has not been assessed using prospective data.OBJECTIVE To evaluate the association of hypertension and antihypertensive medications with risk of psoriasis.DESIGN, SETTING, AND PARTICIPANTS We performed a prospective cohort study (June 1, 1996, to June 1, 2008) of 77 728 US women from the Nurses' Health Study who provided biennially updated data on hypertension and antihypertensive medications.MAIN OUTCOMES AND MEASURES Physician-diagnosed psoriasis.RESULTS A total of 843 incident psoriasis cases were documented during 1 066 339 person-years of follow-up. Compared with normotensive women, women with a hypertension duration of 6 years or more were at a higher risk of developing psoriasis (hazard ratio [HR], 1.27; 95%CI, 1.03-1.57). In stratified analysis, the risk of psoriasis was higher among hypertensive women without medication use (HR, 1.49; 95%CI, 1.15-1.92) and among hypertensive women with current medication use (HR, 1.31; 95%CI, 1.10-1.55) when compared with normotensive participants without medication use. Compared with women who never used β-blockers, the multivariate HRs for psoriasis for women who regularly used β-blockers were 1.11 (95%CI, 0.82-1.51) for 1 to 2 years of use, 1.06 (95%CI, 0.79-1.40) for 3 to 5 years of use, and 1.39 (95%CI, 1.11-1.73) for 6 years or more of use (P for trend = .009). No association was found between use of other individual antihypertensive drugs and risk of psoriasis.CONCLUSIONS AND RELEVANCE Long-term hypertensive status is associated with an increased risk of psoriasis. Long-term regular use of β-blockers may also increase the risk of psoriasis.

AB - IMPORTANCE Individuals with psoriasis have an elevated risk of hypertension, and antihypertensive medications, especially β-blockers, have been linked to psoriasis development. However, the association of prior existing hypertension and antihypertensive medications with risk of incident psoriasis has not been assessed using prospective data.OBJECTIVE To evaluate the association of hypertension and antihypertensive medications with risk of psoriasis.DESIGN, SETTING, AND PARTICIPANTS We performed a prospective cohort study (June 1, 1996, to June 1, 2008) of 77 728 US women from the Nurses' Health Study who provided biennially updated data on hypertension and antihypertensive medications.MAIN OUTCOMES AND MEASURES Physician-diagnosed psoriasis.RESULTS A total of 843 incident psoriasis cases were documented during 1 066 339 person-years of follow-up. Compared with normotensive women, women with a hypertension duration of 6 years or more were at a higher risk of developing psoriasis (hazard ratio [HR], 1.27; 95%CI, 1.03-1.57). In stratified analysis, the risk of psoriasis was higher among hypertensive women without medication use (HR, 1.49; 95%CI, 1.15-1.92) and among hypertensive women with current medication use (HR, 1.31; 95%CI, 1.10-1.55) when compared with normotensive participants without medication use. Compared with women who never used β-blockers, the multivariate HRs for psoriasis for women who regularly used β-blockers were 1.11 (95%CI, 0.82-1.51) for 1 to 2 years of use, 1.06 (95%CI, 0.79-1.40) for 3 to 5 years of use, and 1.39 (95%CI, 1.11-1.73) for 6 years or more of use (P for trend = .009). No association was found between use of other individual antihypertensive drugs and risk of psoriasis.CONCLUSIONS AND RELEVANCE Long-term hypertensive status is associated with an increased risk of psoriasis. Long-term regular use of β-blockers may also increase the risk of psoriasis.

UR - http://www.scopus.com/inward/record.url?scp=84908227493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908227493&partnerID=8YFLogxK

U2 - 10.1001/jamadermatol.2013.9957

DO - 10.1001/jamadermatol.2013.9957

M3 - Article

VL - 150

SP - 957

EP - 963

JO - JAMA Dermatology

JF - JAMA Dermatology

SN - 2168-6068

IS - 9

ER -